Find clinical trials in your area

Search by disease and location to discover available clinical trials matching your criteria.

Matched clinical trials

  • Study of capivasertib tablets in patients with relapsed or refractory B-cell non-Hodgkin lymphoma

    Not recruiting

    1 1 1
    Investigated drugs:
    Spain
  • Study of Rapcabtagene Autoleucel and Ibrutinib for Adults with Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, and Other Blood Cancers

    Not recruiting

    1 1 1
    Austria France Germany Italy Spain
  • Long-Term Access to Ibrutinib for Patients with Lymphoma, Leukemia, and Other Conditions

    Not recruiting

    1 1 1
    Investigated drugs:
    Czechia France Hungary Italy Poland Spain +1
  • Study on MB-CART19.1 for Patients with Relapsed or Refractory CD19 Positive B Cell Malignancies

    Not recruiting

    1 1
    Germany
  • Study of Mosunetuzumab and Zanubrutinib for Patients with Relapsed or Refractory Follicular Lymphoma

    Not recruiting

    1 1 1
    Investigated diseases:
    Italy
  • Study of Tazemetostat with R-CHOP for Newly Diagnosed Diffuse Large B Cell Lymphoma or High-Risk Follicular Lymphoma Patients

    Not recruiting

    1 1 1
    Belgium France
  • Study on Mosunetuzumab and Lenalidomide for Patients with Follicular Lymphoma After Previous Treatment

    Not recruiting

    1 1 1 1
    Investigated diseases:
    France Germany Italy Poland Spain
  • Study on the Effectiveness and Safety of Tisagenlecleucel for Adults with Hard-to-Treat or Returning Follicular Lymphoma

    Not recruiting

    1 1 1
    Investigated drugs:
    Belgium France Germany Italy The Netherlands Norway +1
  • Study of Ibrutinib and Rituximab for Patients with Follicular Lymphoma

    Not recruiting

    1 1
    Investigated diseases:
    Investigated drugs:
    Austria Belgium Czechia France Greece Hungary +5
  • Study of Zanubrutinib and Obinutuzumab for Patients with Relapsed or Refractory Follicular Lymphoma

    Not recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    Czechia France Italy Poland Spain